-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
PetIQ, Inc. (NASDAQ:PETQ) Forecasted to Post Q3 2022 Earnings of ($0.12) Per Share
PetIQ, Inc. (NASDAQ:PETQ) Forecasted to Post Q3 2022 Earnings of ($0.12) Per Share
PetIQ, Inc. (NASDAQ:PETQ – Get Rating) – Jefferies Financial Group issued their Q3 2022 earnings per share estimates for PetIQ in a report issued on Wednesday, September 21st. Jefferies Financial Group analyst C. Grady anticipates that the company will earn ($0.12) per share for the quarter. The consensus estimate for PetIQ's current full-year earnings is $0.80 per share. Jefferies Financial Group also issued estimates for PetIQ's Q4 2022 earnings at ($0.16) EPS, FY2022 earnings at $0.62 EPS, Q1 2023 earnings at $0.49 EPS, Q2 2023 earnings at $0.40 EPS, Q3 2023 earnings at ($0.02) EPS, Q4 2023 earnings at ($0.03) EPS and FY2023 earnings at $0.86 EPS.
Get PetIQ alerts:Separately, Raymond James lowered their price objective on PetIQ from $29.00 to $21.00 in a research report on Wednesday, August 10th.
PetIQ Trading Down 1.1 %
Shares of PETQ stock opened at $8.33 on Friday. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.54 and a current ratio of 2.88. PetIQ has a 52-week low of $8.18 and a 52-week high of $27.09. The company has a market capitalization of $244.99 million, a PE ratio of -17.00, a price-to-earnings-growth ratio of 1.32 and a beta of 1.52. The business's fifty day moving average is $13.17 and its 200 day moving average is $17.07.PetIQ (NASDAQ:PETQ – Get Rating) last issued its quarterly earnings data on Tuesday, August 9th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.18. PetIQ had a positive return on equity of 9.27% and a negative net margin of 1.53%. The company had revenue of $252.01 million for the quarter, compared to the consensus estimate of $259.28 million.
Institutional Investors Weigh In On PetIQ
Large investors have recently added to or reduced their stakes in the company. Byrne Asset Management LLC purchased a new stake in PetIQ during the fourth quarter valued at about $28,000. Captrust Financial Advisors grew its stake in shares of PetIQ by 1,149.6% during the second quarter. Captrust Financial Advisors now owns 1,562 shares of the company's stock valued at $26,000 after buying an additional 1,437 shares during the last quarter. Eagle Bay Advisors LLC grew its stake in shares of PetIQ by 142.9% during the second quarter. Eagle Bay Advisors LLC now owns 1,683 shares of the company's stock valued at $28,000 after buying an additional 990 shares during the last quarter. Amalgamated Bank bought a new position in shares of PetIQ during the first quarter valued at about $107,000. Finally, BNP Paribas Arbitrage SA grew its stake in shares of PetIQ by 20.2% during the fourth quarter. BNP Paribas Arbitrage SA now owns 5,825 shares of the company's stock valued at $132,000 after buying an additional 978 shares during the last quarter.
PetIQ Company Profile
(Get Rating)
PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications.
Featured Stories
- Get a free copy of the StockNews.com research report on PetIQ (PETQ)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.
PetIQ, Inc. (NASDAQ:PETQ – Get Rating) – Jefferies Financial Group issued their Q3 2022 earnings per share estimates for PetIQ in a report issued on Wednesday, September 21st. Jefferies Financial Group analyst C. Grady anticipates that the company will earn ($0.12) per share for the quarter. The consensus estimate for PetIQ's current full-year earnings is $0.80 per share. Jefferies Financial Group also issued estimates for PetIQ's Q4 2022 earnings at ($0.16) EPS, FY2022 earnings at $0.62 EPS, Q1 2023 earnings at $0.49 EPS, Q2 2023 earnings at $0.40 EPS, Q3 2023 earnings at ($0.02) EPS, Q4 2023 earnings at ($0.03) EPS and FY2023 earnings at $0.86 EPS.
PetIQ，Inc.(納斯達克代碼：PETQ-GET Rating)-傑富瑞金融集團在9月21日星期三發佈的一份報告中發佈了他們對PetIQ 2022年第三季度每股收益的估計。傑富瑞金融集團分析師C.Grady預計，該公司本季度每股收益為0.12美元。對PetIQ目前全年收益的普遍估計是每股0.80美元。傑富瑞金融集團還發布了對PetIQ 2022財年第四季度每股收益(0.16美元)、2022財年每股收益0.62美元、2023年第一季度每股收益0.49美元、2023年第二季度每股收益0.40美元、2023年第三季度每股收益(0.02美元)、2023年第四季度每股收益(0.03美元)和2023財年每股收益0.86美元的預期。
Separately, Raymond James lowered their price objective on PetIQ from $29.00 to $21.00 in a research report on Wednesday, August 10th.
另外，雷蒙德·詹姆斯在8月10日星期三的一份研究報告中將PetIQ的目標價從29.00美元下調至21.00美元。
PetIQ Trading Down 1.1 %
PetIQ股價下跌1.1%
PetIQ (NASDAQ:PETQ – Get Rating) last issued its quarterly earnings data on Tuesday, August 9th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.18. PetIQ had a positive return on equity of 9.27% and a negative net margin of 1.53%. The company had revenue of $252.01 million for the quarter, compared to the consensus estimate of $259.28 million.
PetIQ(納斯達克代碼：PETQ-GET Rating)上一次發佈季度收益數據是在8月9日(星期二)。該公司公佈本季度每股收益(EPS)為0.42美元，高於分析師普遍預期的0.24美元和0.18美元。PetIQ的股本回報率為正9.27%，淨利潤率為負1.53%。該公司本季度營收為2.5201億美元，而市場普遍預期為2.5928億美元。
Institutional Investors Weigh In On PetIQ
機構投資者看好PetIQ
Large investors have recently added to or reduced their stakes in the company. Byrne Asset Management LLC purchased a new stake in PetIQ during the fourth quarter valued at about $28,000. Captrust Financial Advisors grew its stake in shares of PetIQ by 1,149.6% during the second quarter. Captrust Financial Advisors now owns 1,562 shares of the company's stock valued at $26,000 after buying an additional 1,437 shares during the last quarter. Eagle Bay Advisors LLC grew its stake in shares of PetIQ by 142.9% during the second quarter. Eagle Bay Advisors LLC now owns 1,683 shares of the company's stock valued at $28,000 after buying an additional 990 shares during the last quarter. Amalgamated Bank bought a new position in shares of PetIQ during the first quarter valued at about $107,000. Finally, BNP Paribas Arbitrage SA grew its stake in shares of PetIQ by 20.2% during the fourth quarter. BNP Paribas Arbitrage SA now owns 5,825 shares of the company's stock valued at $132,000 after buying an additional 978 shares during the last quarter.
大型投資者最近增持或減持了該公司的股份。Byrne Asset Management LLC在第四季度購買了PetIQ的新股份，價值約2.8萬美元。CapTrust Financial Advisors在第二季度增持了1,149.6%的PetIQ股票。CapTrust Financial Advisors現在擁有1,562股該公司股票，價值26,000美元，在上個季度又購買了1,437股。Eagle Bay Advisors LLC在第二季度增持了PetIQ的股份142.9%。Eagle Bay Advisors LLC現在擁有1,683股該公司的股票，價值28,000美元，在上個季度又購買了990股。合併銀行在第一季度購買了PetIQ的新股票頭寸，價值約10.7萬美元。最後，法國巴黎銀行套利公司在第四季度持有的PetIQ股份增加了20.2%。法國巴黎銀行套利公司現在持有該公司5,825股股票，價值13.2萬美元，在上個季度又購買了978股。
PetIQ Company Profile
PetIQ公司簡介
(Get Rating)
(獲取評級)
PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications.
PetIQ，Inc.在美國和國際上作為一家寵物藥物和健康公司運營。它分為兩個部分，產品和服務。該公司提供Rx寵物藥物，其中包括跳蚤和扁蝨控制、心線蟲預防、關節炎、甲狀腺、糖尿病和疼痛治療、抗生素和其他特殊藥物；並開發和製造自己的專有價值品牌產品，以及分銷第三方品牌藥物。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on PetIQ (PETQ)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- 免費獲取StockNews.com關於PetIQ(PETQ)的研究報告
- 華爾街對Datadog的熱情會帶來巨大的收益嗎？
- MarketBeat：回顧一週9/19-9/23
- 為什麼特斯拉的股票保持彈性？
- 好市多盈利後價格疲軟是買入的好時機嗎？
- 需要關注的2只半導體類股走勢逆轉
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.
接受PetIQ Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對PetIQ和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧